Understanding the features of the three approved assays for serum levels of infliximab is important in interpreting the results and adjusting therapy, an Australian study has concluded. Gastroenterologist Dr Susan Connor from the Liverpool Hospital in Sydney, and colleagues used serum from healthy volunteers ‘spiked’ with known concentrations of infliximab to check the performance of ...
Infliximab monitoring: Know your assay
By Tony James
31 Aug 2016